Ozempic subcutaneous injection 2 mg (YJ code: 2499418G4027, standard: 2mg 1.5mL 1 kit), manufactured by Novo Nordisk Pharma, contains semaglutide (genetical recombination). This once-weekly GLP-1 receptor agonist is used to manage type 2 diabetes by improving blood sugar control and can reduce the risk of major cardiovascular events.
Ozempic subcutaneous injection 2 mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →